Teriflunomid Zentiva

Teriflunomide Zentiva is an oral medication used for multiple sclerosis symptom management. It belongs to the immunomodulatory class, helping reduce disease activity. This EU-sourced treatment is taken once daily for broad MS support.

Teriflunomide Zentiva is prescribed to reduce relapses and delay disability progression in adults with relapsing forms of multiple sclerosis. It works by modulating the immune system to limit inflammation in the central nervous system. Patients often use it as part of long-term disease management plans.

Common effects include mild gastrointestinal discomfort, such as nausea or diarrhea, especially when starting treatment. Some users report mild headaches or hair thinning, which are typically temporary. Most people tolerate it well with consistent daily use.

Keep this medication in a cool, dry place away from direct sunlight. Store it securely, out of reach of children and pets. If you experience unusual fatigue or signs of liver issues, contact a healthcare provider promptly. Regular monitoring may be recommended during therapy.

Teriflunomide Zentiva may interact with other immunomodulators or medications affecting liver enzymes. Avoid alcohol while taking this drug, as it can increase liver strain. Inform your doctor about all prescriptions, over-the-counter products, and supplements before starting treatment.